ADAM17 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADAM17 inhibitor, covering 2020-02-19 to 2020-02-19. Get the full timeline:
Most recent: Clinical Trial Update: ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL [Phase 1, Phase 2]